US PATENT SUBCLASS 424 / 179.1-- .~ Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.)

US PATENT SUBCLASS 424 / 179.1
.~ Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.)

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999 Terms of Use

424 /	HD	DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

178.1	DF	CONJUGATE OR COMPLEX OF MONOCLONAL OR POLYCLONAL ANTIBODY, IMMUNOGLOBULIN, OR FRAGMENT THEREOF WITH NONIMMUNOGLOBULIN MATERIAL {3}
179.1		.~ Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.) {2}
180.1	DF	.~.~> Conjugate includes potentiator or composition comprising conjugate includes potentiator
181.1	DF	.~.~> Conjugated to nonproteinaceous bioaffecting compound (e.g., conjugated to cancer-treating drug, etc.)

DEFINITION

Classification: 424/179.1

Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.):

(under subclass 178.1) Subject matter wherein a monoclonal or polyclonal antibody or immunoglobulin or fragment thereof is conjugated to a nonimmunoglobulin material via a linking group, a bond, a chelating agent, or a coupling agent that is specifically identified in the claim(s) by chemical name or chemical structure.